# DETERMINE: Detemir vs NPH

> **NCT05124457** · PHASE2 · RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 336 (estimated)

## Conditions studied

- Gestational Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Detemir
- **DRUG:** Insulin NPH

## Key facts

- **NCT ID:** NCT05124457
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 336 (ESTIMATED)
- **Last updated:** 2023-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05124457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05124457, "DETERMINE: Detemir vs NPH". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05124457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*